BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33920837)

  • 1. The Role of Exosomes in Lysosomal Storage Disorders.
    Gleason AM; Woo EG; McKinney C; Sidransky E
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33920837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicles.
    Do MA; Levy D; Brown A; Marriott G; Lu B
    Sci Rep; 2019 Nov; 9(1):17274. PubMed ID: 31754156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular.
    Buratta S; Tancini B; Sagini K; Delo F; Chiaradia E; Urbanelli L; Emiliani C
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.
    Xia X; Wang Y; Huang Y; Zhang H; Lu H; Zheng JC
    Prog Neurobiol; 2019 Dec; 183():101694. PubMed ID: 31542363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures.
    Miranda AM; Lasiecka ZM; Xu Y; Neufeld J; Shahriar S; Simoes S; Chan RB; Oliveira TG; Small SA; Di Paolo G
    Nat Commun; 2018 Jan; 9(1):291. PubMed ID: 29348617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomes as a therapeutic target.
    Bonam SR; Wang F; Muller S
    Nat Rev Drug Discov; 2019 Dec; 18(12):923-948. PubMed ID: 31477883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid lysosomal storage disorders.
    Platt FM
    Nature; 2014 Jun; 510(7503):68-75. PubMed ID: 24899306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.
    Li W; Cologna SM
    Mol Omics; 2022 May; 18(4):256-278. PubMed ID: 35343995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases.
    Marques ARA; Saftig P
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30651381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases.
    Song Q; Meng B; Xu H; Mao Z
    Transl Neurodegener; 2020 May; 9(1):17. PubMed ID: 32393395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders.
    Tancini B; Buratta S; Sagini K; Costanzi E; Delo F; Urbanelli L; Emiliani C
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31284546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal storage diseases: cellular pathology, clinical and genetic heterogeneity, therapy.
    Reuser AJ; Kroos MA; Visser WJ; Willemsen R
    Ann Biol Clin (Paris); 1994; 52(10):721-8. PubMed ID: 7747880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative lysosomal disorders: a continuum from development to late age.
    Nixon RA; Yang DS; Lee JH
    Autophagy; 2008 Jul; 4(5):590-9. PubMed ID: 18497567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases.
    Annunziata I; Sano R; d'Azzo A
    Cell Death Dis; 2018 Feb; 9(3):328. PubMed ID: 29491402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Co-Localization and Pattern Analysis of Endo-Lysosomal Cargo in Subcellular Image Cytometry and Validation on Synthetic Image Sets.
    Lund FW; Wüstner D
    Methods Mol Biol; 2017; 1594():93-128. PubMed ID: 28456978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered level of plasma exosomes in patients with Gaucher disease.
    Tatiana S; Stanislav N; Darya K; Luiza G; Konstantin S; Sergey L; Elena V; Galina S; Nikolai V; Arthur K; Elena Z; Roman K; Tatiana U; Alexander S; Ekaterina Z; Anton E; Sofya P
    Eur J Med Genet; 2020 Nov; 63(11):104038. PubMed ID: 32822875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exosomal microRNAs in central nervous system diseases.
    Yu Y; Hou K; Ji T; Wang X; Liu Y; Zheng Y; Xu J; Hou Y; Chi G
    Mol Cell Biochem; 2021 May; 476(5):2111-2124. PubMed ID: 33528706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.